Lusher

A randomized, double‐blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors

Shapiro, Kasper, Y. Laurian, 1998 .

2 Fate and Transport of Microplastics in Marine Ecosystems

Lusher, 2021 .

Clinical guidelines for treating von Willebrand disease patients who are not candidates for DDAVP — a survey of European physicians

Lusher, 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with Haemophilia

Lusher, Ragni, Krause, 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation’s Medical and Scientific Advisor

Kulkarni, Henry, Lusher, 1999, Haemophilia : the official journal of the World Federation of Hemophilia.

Human recombinant DNA‐derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5‐year study of home therapy

Kasper, Lusher, Abildgaard, 1999, Haemophilia : the official journal of the World Federation of Hemophilia.

Factor VIII inhibitors with recombinant products : prospective clinical trials. Discussion

J. Lusher, Aledort, Lusher, 2000 .

Immune Status of Human Immunodeficiency Virus Seropositive and Seronegative Hemophiliacs Infused for 3 . 5 Years With Recombinant Factor VI 11

D. Brettler, R. Schwartz, Aledort, 2000 .